The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Metastatic angiosarcomas (mAS): Identification of treatments that significantly improve the outcome.
E. Amela
No relevant relationships to disclose
A. Italiano
No relevant relationships to disclose
I. L. Ray-Coquard
No relevant relationships to disclose
L. Chaigneau
No relevant relationships to disclose
C. Delcambre
No relevant relationships to disclose
B. Bui Nguyen
No relevant relationships to disclose
F. Bertucci
No relevant relationships to disclose
N. Isambert
No relevant relationships to disclose
D. Cupissol
No relevant relationships to disclose
E. Bompas
No relevant relationships to disclose
J. Bay
No relevant relationships to disclose
F. Duffaud
No relevant relationships to disclose
C. Guillemet
No relevant relationships to disclose
N. Corradini
No relevant relationships to disclose
P. A. Cassier
No relevant relationships to disclose
C. Chevreau
No relevant relationships to disclose
J. Blay
No relevant relationships to disclose
N. Penel
No relevant relationships to disclose